Bromethenmadinone acetate (BMMA, also known as bromsuperlutin) is a progestin medication which was developed in Czechoslovakia and was described in 1970 but was never marketed. Analogues of BMMA include chlormethenmadinone acetate, melengestrol acetate, and methenmadinone acetate.
See also List of progestogen esters § Esters of 17α-hydroxyprogesterone derivatives 16-Methylene-17α-hydroxyprogesterone acetate
References